Milnacipran Dose-Effect Study in Patients With Burning Mouth Syndrome

Abstract

From the result of this study, dose escalation of milnacipran for patients with burning mouth syndrome with inadequate response at low doses may be helpful if the 30-mg daily dose has been tolerated well.